ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues | Human Genomics | Full Text
![IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension](https://www.ahajournals.org/cms/asset/c514bc66-af77-4759-b7f9-1503e4f6084b/hypertensionaha.119.13982.fig04.jpg "IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension")
IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension
ACE2: Receptor for COVID-19 Invasion | OriGene
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
COVID-19: Der Einfluss von Antihypertonika
Decoy receptors - Wikipedia
Molecules | Free Full-Text | Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients’ Real Problems: Chronic Dry Cough
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Blockierung des Renin-Angiotensin-Aldosteron-Systems | Die Nephrologie
IJMS | Free Full-Text | Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias
Myocardial Angiotensin Metabolism in End-Stage Heart Failure - ScienceDirect
Pharmaceuticals | Free Full-Text | The Angiotensin II Type 2 Receptor, a Target for Protection and Regeneration of the Peripheral Nervous System?
Engineering ACE2 decoy receptors to combat viral escapability: Trends in Pharmacological Sciences
Expression of ACE2 receptor, soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin (1-7), is modulated in COVID-19 patients | medRxiv
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future - ScienceDirect
Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease - Kidney International
Role of the ACE2/Ang-(1-7)/Mas axis in glucose metabolism
COVID-19, ACE -inhibitors and angiotensin receptor blockers: The need to differentiate between early infection and acute lung injury
ACE-Hemmer | Gelbe Liste
Frontiers | The emerging multifunctional roles of ERAP1, ERAP2 and IRAP between antigen processing and renin-angiotensin system modulation
ACE2 mouse models: a toolbox for cardiovascular and pulmonary research | Nature Communications
Figures
Leichtes Spiel für SARS-CoV-2?
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic - Figure f2 | Aging
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
